Tilray Brands, Inc. Repayments of Other Long-term Debt
Tilray Brands, Inc. (TLRY) reported Repayments of Other Long-term Debt of $25.35 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherLongTermDebt · last filed 2026-07-28
- Tilray Brands, Inc. repayments of other long-term debt for the quarter ending 2026-05-31 was $14.24M.
- Tilray Brands, Inc. repayments of other long-term debt for the quarter ending 2026-02-28 was $4.24M, a 26.03% decline year-over-year.
- Tilray Brands, Inc. repayments of other long-term debt for the quarter ending 2025-11-30 was $4.22M, a 24.62% decline year-over-year.
- Tilray Brands, Inc. repayments of other long-term debt for the quarter ending 2025-08-31 was $2.65M, a 44.63% decline year-over-year.
- Tilray Brands, Inc. repayments of other long-term debt for fiscal 2026 was $25.35M, a 63.50% increase from fiscal 2025.
- Tilray Brands, Inc. repayments of other long-term debt for fiscal 2025 was $15.51M, a 30.78% decline from fiscal 2024.
- Tilray Brands, Inc. repayments of other long-term debt for fiscal 2024 was $22.40M, a 5.00% increase from fiscal 2023.
- Tilray Brands, Inc. repayments of other long-term debt for fiscal 2023 was $21.34M, a 47.00% decline from fiscal 2022.
| Period end | Repayments of Other Long-term Debt 3 month | Repayments of Other Long-term Debt 6 month | Repayments of Other Long-term Debt 9 month | Repayments of Other Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-05-31 | $14.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $18.48M derived: sum of 2 quarters · filed 2026-07-28 | $22.70M derived: sum of 3 quarters · filed 2026-07-28 | $25.35M 10-K · filed 2026-07-28 |
| 2026-02-28 | $4.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $8.46M derived: sum of 2 quarters · filed 2026-04-01 | $11.11M 10-Q · filed 2026-04-01 | $10.50M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-11-30 | $4.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $6.87M 10-Q · filed 2026-01-08 | $6.26M derived: sum of 3 quarters · filed 2026-07-28 | $11.99M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-08-31 | $2.65M 10-Q · filed 2025-10-09 | $2.04M derived: sum of 2 quarters · filed 2026-07-28 | $7.77M derived: sum of 3 quarters · filed 2026-07-28 | $13.37M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-05-31 | -$609.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $5.12M derived: sum of 2 quarters · filed 2026-07-28 | $10.71M derived: sum of 3 quarters · filed 2026-07-28 | $15.51M 10-K · filed 2026-07-28 |
| 2025-02-28 | $5.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-01 | $11.32M derived: sum of 2 quarters · filed 2026-04-01 | $16.11M 10-Q · filed 2026-04-01 | $20.54M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | $5.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $10.39M 10-Q · filed 2026-01-08 | $14.81M derived: sum of 3 quarters · filed 2026-07-28 | $17.89M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $4.79M 10-Q · filed 2025-10-09 | $9.21M derived: sum of 2 quarters · filed 2026-07-28 | $12.29M derived: sum of 3 quarters · filed 2026-07-28 | $20.82M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $7.50M derived: sum of 2 quarters · filed 2026-07-28 | $16.03M derived: sum of 3 quarters · filed 2026-07-28 | $22.40M 10-K · filed 2026-07-28 |
| 2024-02-29 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-08 | $11.61M derived: sum of 2 quarters · filed 2025-04-08 | $17.98M 10-Q · filed 2025-04-08 | -$25.34M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | $8.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-10 | $14.90M 10-Q · filed 2025-01-10 | -$28.42M derived: sum of 3 quarters · filed 2025-07-29 | $25.82M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | $6.37M 10-Q · filed 2024-10-10 | -$36.95M derived: sum of 2 quarters · filed 2025-07-29 | $17.29M derived: sum of 3 quarters · filed 2025-07-29 | |
| 2023-05-31 | -$43.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $10.92M derived: sum of 2 quarters · filed 2025-07-29 | $21.34M 10-K · filed 2025-07-29 | |
| 2023-02-28 | $54.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $64.66M 10-Q · filed 2024-04-09 | ||
| 2022-11-30 | $10.42M 10-Q · filed 2024-01-09 | |||
| 2022-05-31 | $40.25M 10-K · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |